Cognition To Host Virtual KOL In Mid-April
Date
4/1/2024 10:10:19 AM
(MENAFN- Baystreet) Agilent Gains on Dilution System
Brown-Forman Strikes Deal in Japan, Shares Slump
Prenetics Flat on
financial Results
Monday's Stock Movers
UPS Becomes Air Cargo Provider For The U.S. Postal Service Previous Articles Subscribe to Get Small Cap News & Alerts Glenn Wilkins - Monday, April 1, 2024
Cognition to Host Virtual KOL in Mid-April
Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, today announced it will host a virtual KOL event on Friday, April 12, from 8:00 AM to 9:30 AM ET. The live and archived event may be accessed from the investor relations section of the Cognition website.
The event will feature three experts who will provide insights on the unmet need and the current treatment landscape for Alzheimer's disease, as well as anti-amyloid beta monoclonal antibody drug launches, and commercial uptake.
In addition, the KOLs and Cognition management will discuss CT1812, Cognition's novel oral once-daily sigma-2 (s-2) receptor modulator designed to displace Aß oligomers from their binding sites on neurons. Topics will include details of its mechanism of action and ongoing clinical development program in Alzheimer's disease, which includes the Phase 2 START Study in people with early stage disease and the Phase 2 SHINE Study in people with mild-to-moderate Alzheimer's disease. Topline results from the SHINE Study are anticipated in mid-2024.
A live question and answer session will follow formal presentations.
Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative disorders of the central nervous system and retina.
CGTX shares grabbed a penny to open Monday at $1.83.
About Us Contact Us Advertise License Our Content Jobs Disclaimer Privacy Policy
Copyright 1998 - 2024 Baystreet Media Corp. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes. Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Market Data is provided by QuoteMedia. Earnings by Zacks. Analyst Ratings by Zacks
MENAFN01042024000212011056ID1108044214
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.